Analysts Set Oak Street Health, Inc. (NYSE:OSH) Price Target at $34.81

Shares of Oak Street Health, Inc. (NYSE:OSHGet Rating) have been assigned an average rating of “Moderate Buy” from the eighteen analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $35.50.

Several analysts have weighed in on OSH shares. Sanford C. Bernstein started coverage on shares of Oak Street Health in a research note on Thursday, May 26th. They issued an “outperform” rating and a $26.00 price target for the company. Bank of America downgraded shares of Oak Street Health from a “buy” rating to an “underperform” rating and lowered their price target for the stock from $26.00 to $18.00 in a research note on Wednesday, June 15th. Barclays boosted their price target on shares of Oak Street Health from $27.00 to $31.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 19th. SVB Leerink upped their price objective on shares of Oak Street Health from $23.00 to $32.00 and gave the company a “market perform” rating in a research note on Thursday. Finally, Argus assumed coverage on shares of Oak Street Health in a research note on Tuesday, July 26th. They set a “hold” rating for the company.

Oak Street Health Stock Performance

Oak Street Health stock opened at $30.29 on Monday. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 16.10. The company has a market capitalization of $7.30 billion, a PE ratio of -13.77 and a beta of 3.05. The firm has a fifty day simple moving average of $21.54 and a two-hundred day simple moving average of $20.69. Oak Street Health has a twelve month low of $13.29 and a twelve month high of $64.75.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.04). The business had revenue of $513.80 million during the quarter, compared to the consensus estimate of $506.82 million. Oak Street Health had a negative return on equity of 716.26% and a negative net margin of 27.11%. The business’s revenue for the quarter was up 73.2% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.29) earnings per share. Research analysts expect that Oak Street Health will post -2.17 EPS for the current year.

Insider Activity at Oak Street Health

In other Oak Street Health news, insider Geoffrey M. Price sold 120,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The shares were sold at an average price of $18.91, for a total value of $2,269,200.00. Following the sale, the insider now owns 1,893,270 shares in the company, valued at $35,801,735.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Oak Street Health news, insider Geoffrey M. Price sold 120,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The shares were sold at an average price of $18.91, for a total value of $2,269,200.00. Following the sale, the insider now owns 1,893,270 shares in the company, valued at $35,801,735.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Brian Clem sold 40,000 shares of the company’s stock in a transaction dated Tuesday, August 2nd. The stock was sold at an average price of $30.00, for a total transaction of $1,200,000.00. Following the completion of the sale, the chief operating officer now owns 596,468 shares in the company, valued at approximately $17,894,040. The disclosure for this sale can be found here. Insiders have sold 1,014,413 shares of company stock worth $25,854,151 over the last 90 days. 11.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Capital International Investors lifted its stake in shares of Oak Street Health by 9.3% in the fourth quarter. Capital International Investors now owns 15,122,281 shares of the company’s stock worth $501,362,000 after buying an additional 1,289,911 shares in the last quarter. Capital Research Global Investors lifted its stake in shares of Oak Street Health by 61.0% in the first quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock worth $318,584,000 after buying an additional 4,491,941 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Oak Street Health by 1.8% in the first quarter. Vanguard Group Inc. now owns 10,238,348 shares of the company’s stock worth $275,207,000 after buying an additional 181,216 shares in the last quarter. Capital World Investors lifted its stake in shares of Oak Street Health by 44.5% in the fourth quarter. Capital World Investors now owns 5,966,260 shares of the company’s stock worth $197,722,000 after buying an additional 1,836,533 shares in the last quarter. Finally, Route One Investment Company L.P. lifted its stake in shares of Oak Street Health by 92.9% in the first quarter. Route One Investment Company L.P. now owns 5,725,037 shares of the company’s stock worth $153,889,000 after buying an additional 2,756,500 shares in the last quarter. Institutional investors own 91.42% of the company’s stock.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Articles

Analyst Recommendations for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.